🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s NUVB Holdings & Trades

First Buy
Q1 2026
Duration Held
3 Quarters
Largest Add
Q3 2026
+267,032 Shares
Current Position
267,032 Shares
$1.5 M Value

Paul Tudor Jones's NUVB Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 267,032 shares of Nuvation Bio Inc. (NUVB) worth $1.5 M, representing 0.00% of the portfolio. First purchased in 2026-Q1, this short-term holding has been held for 3 quarters.

Based on 13F filings, Paul Tudor Jones has maintained this position in NUVB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 267,032 shares. Largest reduction occurred in Q2 2026, reducing 177,260 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's Nuvation Bio (NUVB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Nuvation Bio (NUVB) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +267,032 New Buy 267,032 $5.60
Q2 2026 -177,260 Sold Out 0 $0.00
Q1 2026 +177,260 New Buy 177,260 $4.29

Paul Tudor Jones's Nuvation Bio Investment FAQs

Paul Tudor Jones first purchased Nuvation Bio Inc. (NUVB) in Q1 2026, acquiring 177,260 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held Nuvation Bio Inc. (NUVB) for 3 quarters since Q1 2026.

Paul Tudor Jones's largest addition to Nuvation Bio Inc. (NUVB) was in Q3 2026, adding 267,032 shares worth $1.5 M.

According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 267,032 shares of Nuvation Bio Inc. (NUVB), valued at approximately $1.5 M.

As of the Q3 2026 filing, Nuvation Bio Inc. (NUVB) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in Nuvation Bio Inc. (NUVB) was 267,032 shares, as reported at the end of Q3 2026.